Please login to the form below

Not currently logged in
Email:
Password:

AR

This page shows the latest AR news and features for those working in and with pharma, biotech and healthcare.

Janssen will not seek regulatory approval for Erleada plus Zytiga in prostate cancer

Janssen will not seek regulatory approval for Erleada plus Zytiga in prostate cancer

A prespecified analysis also showed that patients aged 75 years or older and those with visceral metastasis, luminal type in PAM50 test and tumours with average or high androgen receptor (AR)

Latest news

  • J&J bags FDA breakthrough designation for prostate cancer drug J&J bags FDA breakthrough designation for prostate cancer drug

    Patients must have received prior taxane chemotherapy and androgen receptor (AR)-targeted therapy prior to beginning niraparib treatment.

  • Aimmune wins over ICER for peanut allergy product Aimmune wins over ICER for peanut allergy product

    Analysts predict blockbuster status for first-in-class. Aimmune is still a few months away from a potential US approval of its peanut allergy drug AR-101, but already has a ... Aimmune says ICER has concluded AR-101 is actually more cost-effective than

  • La La Land? The myth of multichannel excellence La La Land? The myth of multichannel excellence

    79% of adult internet users are on Facebook (Pew). Pokemon Go gained over 20 million daily active users in 2016, demonstrating AR’s potential for mass engagement (Gamespot).

  • Virtual reality Virtual reality

    Facebook chief executive Mark Zuckerberg seems to be enamoured with VR, saying recently he sees it and the related augmented reality (AR) - which layers computer-generated objects into the real-world - ... Other companies working on VR and AR in the

  • Novartis' glaucoma combo cleared in Europe Novartis' glaucoma combo cleared in Europe

    Pharmaceuticals (AR-13324 and PG324; phase III); Kowa (K-115; phase III); Amakem Therapeutics (AMA0076; phase II) and Altheos (ATS907; phase II).

More from news
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 23 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics